1. Home
  2. GANX vs RGS Comparison

GANX vs RGS Comparison

Compare GANX & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$1.80

Market Cap

76.4M

Sector

Health Care

ML Signal

HOLD

Logo Regis Corporation

RGS

Regis Corporation

HOLD

Current Price

$27.63

Market Cap

68.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GANX
RGS
Founded
2017
1922
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
76.4M
68.7M
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
GANX
RGS
Price
$1.80
$27.63
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.50
N/A
AVG Volume (30 Days)
684.8K
4.1K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
31.46
20.24
EPS
N/A
0.89
Revenue
$55,180.00
$210,134,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$31.39
Revenue Growth
N/A
3.52
52 Week Low
$1.41
$18.23
52 Week High
$4.34
$31.50

Technical Indicators

Market Signals
Indicator
GANX
RGS
Relative Strength Index (RSI) 47.40 51.62
Support Level $1.66 $25.95
Resistance Level $2.15 $28.44
Average True Range (ATR) 0.14 0.78
MACD -0.00 0.06
Stochastic Oscillator 19.64 63.41

Price Performance

Historical Comparison
GANX
RGS

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

Share on Social Networks: